Connection
Frits Van Rhee to Chemokine CXCL10
This is a "connection" page, showing publications Frits Van Rhee has written about Chemokine CXCL10.
|
|
Connection Strength |
|
|
|
|
|
0.025 |
|
|
|
-
Zonder JA, Mohrbacher AF, Singhal S, van Rhee F, Bensinger WI, Ding H, Fry J, Afar DE, Singhal AK. A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma. Blood. 2012 Jul 19; 120(3):552-9.
Score: 0.025